English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Robert Hadley | Jul 5, 2017

AbbVie shares findings of leukemia drug study at Madrid conference

+ Technology/Innovation
Robert Hadley | Jul 5, 2017

AstraZeneca’s Faslodex to treat breast cancer a step closer to approval in Europe

+ Regulatory
Robert Hadley | Jul 5, 2017

European regulators consider expanding use of Amgen parathyroid drug to young patients

+ Technology/Innovation
Robert Hadley | Jul 5, 2017

Breastfeed longer to enjoy cardiovascular health benefits, American Heart Association says

+ Regulatory
Michael McGrady | Jul 5, 2017

Policy experts weigh in on new executive order on drug pricing

+ Regulatory
Erianne Leatherman | Jul 2, 2017

Pfizer’s cardiomyopathy drug, tafamidis, on FDA fast track

+ Technology/Innovation
Nicholas Gueguen | Jul 2, 2017

Study indicates connection between alcoholic liver disease, intestinal fungi

+ Community
Nicholas Gueguen | Jul 2, 2017

Pfizer assembles findings from 13 cancers for American Society of Clinical Oncology

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 379
  • 380
  • 381
  • 382
  • 383
  • 384
  • 385
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily